Health News Digest recently published an article discussing Sunridge International's (OTCBB: SNDZ) patented "PNT" procedure. The article was published on January 24, 2010. The article teaches the public about severe glaucoma and what preventative actions can be taken.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
The article mentions how "PNT" can be used for recently diagnosed patients who have not yet tried pharmaceutical approaches. The company is working to increase their marketing efforts to help the newly diagnosed population, along with current glaucoma sufferers, to stop the progression of the disease.
Pneumatic Trabeculoplasty is a new, safe, non-invasive procedure which has been clinically demonstrated (1-6) to further reduce elevated Intraocular Pressure (IOP) in patients already undergoing pharmaceutical treatments (beta-blockers, prostaglandins, adrenergics, etc) and have not been able to achieve their ‘target IOP’ values. PNT can also be used in the newly diagnosed patients who has yet to undergo pharmaceutical approaches.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
